Moffitt Cancer Center’s Post

While at #ASH24, Shrinjaya B Thapa, MD shared a retrospective analysis of clinical characteristics and outcomes of patients with MYD88 positive Waldenström macroglobuliemia. Read more: https://lnkd.in/eigxaR-a American Society of Hematology #MoffittASH24

At #ASH24, Ciara Freeman, MD presented a new CAR T-cell therapy that shows high success rates and manageable side effects for advanced #MultipleMyeloma. Read more: https://lnkd.in/ebbkUcyB American Society of Hematology #ASH24

During #ASH24, Wael Gamal, PhD discusses identifying the role of endoplasmic reticulum stress in CLL T-cell dysfunction. Read more: https://lnkd.in/eJsXp-td American Society of Hematology #MoffittASH24

While at #ASH24, Lauren Peres, PhD highlighted racial and ethnic differences in outcomes of #MultipleMyeloma patients treated with idecabtagene vicleucel or ciltacabtagene autoleucel. Read more: https://lnkd.in/eqWgCWBA American Society of Hematology #MoffittASH24

At #ASH24, Hammad Tashkandi, MD discussed the clinical relevance in classification methods and the prognostic implications of subgrouping within TP53-mutated myelodysplastic neoplasms as outlined by WHO and ICC. Read more: https://lnkd.in/e_SzcJXH American Society of Hematology #MoffittASH24

IACH News of the week 27 - October - 2024 • Here is the weekly summary of the latest in hematology Mohamad Mohty International Academy for Clinical Hematology (IACH) Controversies in Multiple Myeloma (COMy) CME Congresses https://lnkd.in/dSz-KtSy

Today we are working at conference EHA-KCS Hematology Tutorial on Recent Advances in Lymphoid and Myeloid Malignancies

At #ASH24, Moazzam Shahzad, MD discussed bleeding and thrombotic complications of JAK inhibitors in hematological conditions. Read more: https://lnkd.in/eeq5-TRu #MoffittASH24 American Society of Hematology

Thanks, Richard! Today, I presented my recent results and insights on transcriptomic MYC activation in CLL. Long story short, high MYC transcriptomic activation is associated with increased interactions with the TME, suggesting MYC as an orchestrator of TME interactions and explaining why it is linked to various cellular processes. #eha #eha2024

IACH News of the week 20/October • 2024. Here is this week’s newsletter. A brief, up-to-date summary of the last week in hematology. https://lnkd.in/dSz-KtSy International Academy for Clinical Hematology (IACH) Mohamad Mohty CME Congresses Controversies in Multiple Myeloma (COMy)